Phosphatase-independent activity of smooth-muscle calcineurin orchestrates a gene expression program leading to

Paula Sofía Yunes-Leites1,2, Yilin Sun2,3, Sara Martínez-Martínez1,2

  • 1Gene Regulation in Cardiovascular Remodeling and Inflammation Group, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.

Plos Biology
|May 14, 2025
PubMed

Insights

Calcineurin (Cn) in smooth muscle cells (SMCs) drives Angiotensin-II (Ang-II) induced hypertension and abdominal aortic aneurysm (AAA). This structural role of SMC calcineurin, independent of phosphatase activity, highlights PAI-1 as a potential therapeutic target for hypertension.

Area of Science:

  • Vascular Biology
  • Cardiovascular Physiology
  • Molecular Medicine

Background:

  • Angiotensin-II (Ang-II) promotes vascular remodeling in hypertension and abdominal aortic aneurysm (AAA).
  • Calcineurin (Cn) phosphatase activity mediates Ang-II-induced AAA, but the specific cell type involved was unknown.
  • Understanding the precise role of Cn in Ang-II-driven vascular pathologies is crucial.

Purpose of the Study:

  • To determine the cell-specific role of calcineurin (Cn) in Angiotensin-II (Ang-II) induced abdominal aortic aneurysm (AAA) and hypertension.
  • To investigate the mechanisms underlying Cn's function in vascular pathophysiology.
  • To identify novel therapeutic targets for Ang-II-mediated cardiovascular diseases.

Main Methods:

  • Generation of smooth muscle cell (SMC)-specific and endothelial cell (EC)-specific Cn-deficient mice (SM-Cn-/- and EC-Cn-/-).
  • Administration of Ang-II to induce hypertension and AAA in genetically modified mice.
  • Analysis of gene expression, protein activity, and vascular contractility.
  • Pharmacological inhibition of PAI-1 (Serpine1 protein).

Main Results:

  • Cn in SMCs, not ECs, is essential for Ang-II-induced AAA.
  • SMC Cn plays a structural role in Ang-II-induced hypertension, independent of its phosphatase activity.
  • Cn signaling in SMCs regulates ~90% of Ang-II-responsive genes in the aorta, impacting SMC contractility.
  • Serpine1 induction by Ang-II, mediated by Smad2 and structural Cn, is critical for hypertension; PAI-1 inhibition regresses hypertension.

Conclusions:

  • Calcineurin in smooth muscle cells is a key mediator of Ang-II-induced vascular pathologies, including AAA and hypertension.
  • Cn's structural, non-enzymatic role in regulating SMC contractility and gene expression is critical.
  • PAI-1 emerges as a significant downstream effector and a potential therapeutic target for hypertension.

Related Concept Videos

Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.0K
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.1K
Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
477
Smooth Muscle Contraction01:25

Smooth Muscle Contraction

Smooth muscle contraction is a complex process vital for various bodily functions, from maintaining blood vessel tension to facilitating the movement of food through the digestive tract. Unlike striated muscles, smooth muscle contraction begins more slowly and lasts longer.
The onset of contraction is triggered by an increase in calcium ions within the sarcoplasm, similar to the process in striated muscle. However, smooth muscles have a relatively smaller reservoir of the sarcoplasmic...
2.6K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.4K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
2.4K